Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS · Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
At close: Oct 21, 2026
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $994 as of October 22, 2026. It is the 52,421st most valuable company in the world and the 8,431st biggest in the United States. Its market cap has decreased by 92.98% in one year.
Market Cap
994.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,431 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 994.00, a decrease of -100.00%. That is a compound annual growth rate of -83.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 994.00 | -92.79% |
| Dec 31, 2025 | 13.79K | -99.55% |
| Dec 31, 2024 | 3.07M | -18.06% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
| Feb 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Affimed | 1.64K |
| ZIM Corporation | 1.63K |
| DNAPrint Genomics | 1.30K |
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| EV Biologics | 1.02K |
| American Oriental Bioengineering | 949.00 |
| eFFECTOR Therapeutics | 941.00 |